CPG for Psychosocial Interventions in Severe Mental ... - GuíaSalud

Appendix 7. Declaration of interest
All the members of the development team, expert collaborators and external reviewers have declared
no conflict of interest.
Milagros Escusa Julián, Francisco Galán Calvo, Laura Gracia López, Pedro Pibernat
Deulofeu, Ana Vallespí Cantabrana, Juan Ignacio Martín Sánchez, Maria José Vicente Edo, José
Mª Álvarez Martínez, Daniel Navarro Bayón, Antonio Lobo Satué, Julián Carretero Román,
Carlos Cuevas Yust, Begoña Iriarte Campo, Juan Francisco Jiménez Estévez, José Manuel Lalana
Cuenca, Marcelino López Álvarez, Mercedes Serrano Miguel, Catalina Sureda García, Oscar
Vallina Fernández, have declared no interests.
Francisco Caro Rebollo has received funding (Janssen, Boehringer Ingelheim, Lundbeck,
GSK and Novartis) for attending meetings, courses and congresses. He has obtained fees (Janssen)
as a speaker at courses and conferences. He has also received economic aid to participate in research
projects (Bristol Myers-Squibb, AstraZeneca, Esteve / Novartis, Janssen, Lilly.
Concepción de la Cámara Izquierdo has received funding for attending meetings, courses
and congresses (Esteve, Boerhringer, Pfizer, Janssen, Almirall, Boehringer Ingelheim). She has
obtained fees as a speaker at courses and conferences (Andromaco, Bexal and Janssen).
Andrés Martín Gracia has received funding for meetings, congresses and for attending
courses (Boehringer Ingelheim, GSK, Janssen) and fees as a speaker at conferences and courses
(Pfizer and Lilly). He has also received funding for educational programmes or courses (Janssen).
Miguel Martínez Roig has obtained financing for participating in meetings, congresses and
courses (Almirall, Janssen, Lundbeck, Lilly, Boheringer, Bristol-Myer, Wyeth). He has also received
economic support to participate in research projects (Lilly, Pfizer and Janssen).
Mª Esther Samaniego de Corcuera has received funding for participating in meetings, congresses
and courses (Lilly).
Fernando Cañas de Paz has received funding (Servier, Lundbeck and Janssen) to attend to
meetings, courses and congresses, and for participating in research projects. He has also received
fees as a speaker (Janssen, BMS) and for consultancy work (Janssen).
Mª Consuelo Carballal Balsa has received funding for participating in courses, conferences
and meetings (Janssen).
Alberto Fernández Liria has received support (Janssen) to participate in conferences and
fees as a speaker (Lilly, Bristol-Myers Squibb, Wyeth and Lundbeck). He has also received funding
for participating in research projects (Wyeth, Pharma Consult Services).
Miguel Bernardo Arroyo has received fees as a speaker (Lilly, BMS, Wyeth, Janssen and
Pfizer). He has also received economic aid to finance research (BMS) and educational programmes
or courses (Pfizer).
Manuel Camacho Laraña has received economic support to finance his participation in conferences
(Janssen, Lilly and GSK); and fees as a speaker (GSK and AstraZeneca).
Juan José Uriarte Uriarte has obtained funding to participate in a congress and in a research
project (AstraZeneca).
142 CLINICAL PRACTICE GUIDELINES IN THE SPANISH NHS